The global generics drug market is anticipated to grow to $574.63 billion by 2030 owing to the increasing application of robotic process automation, branded medicine patent expiries, and the rising prevalence of chronic diseases. New generic versions are compared to approved drug products known as Reference Listed Drugs (RLDs) to demonstrate their bioequivalence. A pharmaceutical business seeking to offer a generic equivalent must cite the Reference Listed Drug in its regulatory applications. Invimeds sources and provides RLDs globally. We have an excellent network of validated suppliers across the EU, USA, Korea, Latam, and Japan and can procure pharmaceutical products directly and securely for most major pharmaceutical companies.
Currently catering to more than 25+ major players and helping 75+ companies in the healthcare industry
Registered with 40+ Pharma Companies as an approved vendor to their organization
We operate an EU-certified warehouse, which meets EU GDP guidelines, and follows a set of Standard Operating Practices(SOPs) written according to mandates provided by the EU.
We have a well-established network of suppliers that have been carefully validated and authenticated
To keep you informed and help you plan your study appropriately, our team will regularly provide updates and advise of product shortages or manufacturer delays.
Our partnership with leading logistic companies for cold storage and shipment, as well as routine deliveries, ensures that products are delivered at the client warehouse or the landing port without temperature excursion
At Invimeds Health, we believe in offering innovative strategies for an unparalleled experience. Communicate with our experts and learn more about how we can help you with our expertise in Reference Listed Drugs. We follow the Standard Operating Procedures to ensure hassle-free trials. Our team of qualified experts possess years of knowledge in the RLD industry catering to the comprehensive needs of the customers.
Have an inquiry or some feedback for us? Fill out the form below to contact our team
RLDs (Reference Listed Drugs) are brand-name medications that have been authorized by regulatory agencies. They serve as the standard for generic drug makers, ensuring the safety, effectiveness, and quality of generic medications. RLDs are critical to the pharmaceutical industry’s ability to maintain uniform standards.
Invimeds Health has formed alliances with respected manufacturers and suppliers all around the world. We leverage our wide network to quickly procure RLDs for pharmaceutical firms and clinical studies. Our stringent quality controls assure the medications’ validity and dependability.
Yes, Invimeds Health provides regulatory support for RLD suppliers. We have a team of professionals who are familiar with legal pharmaceutical standards, and we can help pharmaceutical companies meet the standards for procuring and employing RLDs in their products or clinical studies.
Yes, Our company is dedicated to the global supply of Reference or Innovator drug.
We can provide documents including COA(Certificate of Analysis), COC(Certificate of Conformity), COO(Certificate of Origin), Packing list, and Country invoices.
To become most Valued & Trusted partner for access to medicines. Driven by Knowledge and Services, InviMeds to become essential to its customers by providing access to most advanced treatment medicines and related services to help improve people’s quality of life.
© 2023 Invimeds. All Rights Reserved.
